Skip to main content

Table 1 Main clinical characteristics of patients according to CAGTA results

From: Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients

 

No. of patients (%)

 
 

Total

CAGTA +

CAGTA -

p value

Patients

53

22 (41.5)

31 (58.5)

-

Age (years)

71.5 ± 18.4

69.2 ± 22.2

73.1 ± 15.3

0.46

Male:Female (ratio)

1.65

1.2

2.3

0.25

APACHE II (score)

14.9 ± 5.4

12.2 ± 4.4

16.9 ± 5.2

0.001

Septic shock

15 (28.3)

4 (18.2)

11 (35.4)

0.16

Respiratory failure

15 (28.3)

7 (31.8)

8 (25.8)

0.63

Coma

5 (9.4)

2 (9.1)

3 (9.7)

0.92

Renal failure

24 (45.3)

6 (27.3)

18 (58.1)

0.02

Extra-renal depuration

16 (30.2)

4 (18.2)

12 (38.7)

0.1

Hepatic failure

19 (35.8)

9 (40.9)

8 (25.8)

0.24

Neutropenia

4 (7.5)

0

4 (12.9)

0.1

Broad spectrum antibiotics

36 (67.9)

17 (77.3)

19 (61.3)

0.21

Parenteral nutrition

33 (62.3)

14 (63.7)

19 (61.3)

0.86

Hepatic transplant

2 (3.8)

1 (4.5)

1 (3.2)

0.80

Acute pancreatitis

3 (5.7)

2 (9.1)

1 (3.2)

0.36

Diabetes mellitus

12 (22.6)

4 (18.2)

8 (25.8)

0.51

Previous surgery

20 (37.7)

12 (54.5)

8 (25.8)

0.03

  1. CAGTA: Candida albicans germ tube antibody